قارن الطرق

	مقياس إدمونتون للوهن (Edmonton Frail Scale - EFS)	المقابلة الهاتفية للحالة المعرفية
المجال	علم الشيخوخة	علم الشيخوخة
العائلة	Process / pipeline	Process / pipeline
سنة النشأة	2006	1988
صاحب الطريقة	Darryl B. Rolfson	J.C. Breitner
النوع	Clinician-administered assessment	Telephone-administered cognitive interview
المصدر التأسيسي	Rolfson, D. B., Majumdar, S. R., Tsuyuki, R. T., Tahir, A., & Srivastava, S. (2006). Validity and reliability of the Edmonton Frail Scale. Age Ageing, 35(5), 526-529.	Breitner, J. C., Folstein, M. F., & Murphy, E. A. (1989). Familial aggregation in Alzheimer dementia: comparison of risk estimates. Genet Epidemiol, 6(1), 35-45.
الأسماء البديلة	EFS, Edmonton Frailty Scale	TICS, TICS-m, Modified Telephone Interview for Cognitive Status
ذات صلة	5	5
الملخص	The Edmonton Frail Scale (EFS) is a comprehensive, nine-domain assessment tool developed by Rolfson and colleagues in 2006 to systematically evaluate frailty across multiple physiological and functional dimensions in older adults. Combining clinical judgment with objective testing, the EFS assesses cognition, general health status, functional independence, social support, medication use, nutrition, mood, continence, and functional performance, providing a multidimensional frailty profile. It is widely used in geriatric clinics, acute care settings, and research to characterize the nature and severity of frailty.	The Telephone Interview for Cognitive Status (TICS) is a telephone-administered cognitive screening instrument developed by Breitner and colleagues in the late 1980s and modified (TICS-m) to assess cognitive function in older adults via remote interview. Designed for epidemiological studies and clinical research where in-person assessment is impractical or resource-intensive, the TICS combines questions assessing orientation, attention, language, memory, and reasoning in a format suitable for administration by trained interviewers without specialized clinical equipment. It has become widely used in longitudinal cohort studies, clinical trials, and telemedicine settings for cognitive screening and monitoring.